查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2059104

機器人手術市場預測至2034年－全球分析（按組件、手術類型、機器人類型、技術、應用、最終用戶和地區分類）

Robotic Surgery Market Forecasts to 2034 - Global Analysis By Component (Robotic Systems, Accessories & Instruments, and Services), Surgery Type, Robot Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球機器人手術市場規模將達到 84 億美元，到 2034 年將達到 267 億美元，預測期內複合年成長率為 15.5%。

機器人手術是指利用電腦控制的機器人系統進行的微創手術。該系統能夠將外科醫生的手部動作轉化為在患者體內進行精準的器械操作。這些系統包括手術主機、配備機械臂的病患推車以及先進的影像處理組件，可提供放大的高清影像。機器人手術透過提高手術靈敏度、減少手部併發症以及進入狹窄的解剖空間，在眾多外科領域中提升了手術精度，減少了術後併發症，並加快了患者的康復。

對微創手術的需求日益成長，以及患者治療效果的改善。

由於微創手術具有許多優勢，包括出血量少、住院時間短、感染風險低以及能更快恢復日常生活，患者和醫療服務提供者越來越傾向於選擇微創手術。機器人系統比傳統腹腔鏡器械具有更高的精準度和控制力，使外科醫生更有信心地完成複雜的手術。隨著泌尿系統、婦科和一般外科領域臨床療效的不斷提升，機器人手術的應用正從大學附屬醫院加速擴展到社區醫院。隨著外科醫生和患者對微創手術的認知不斷提高，採用機器人手術平台的手術數量也穩定成長。

機器人手術系統初始成本高昂，維護成本也高。

機器人手術系統的實施需要數百萬美元的初始投資，這構成了一個巨大的財務障礙，尤其對於新興市場的區域醫院和醫療機構更是如此。除了初始投資外，諸如器械更換、軟體許可、維護合約和外科培訓項目等持續性成本也構成了沉重的經常性財務負擔。許多醫療體系的報銷機制無法跟上機器人手術的實際成本，這給醫院的利潤率帶來了壓力。這些經濟限制使得機器人手術的應用範圍僅限於大規模三級醫療機構，儘管臨床支持強勁，但其市場滲透速度仍然緩慢。

人工智慧整合式自主手術機器人平台的出現。

人工智慧與機器人手術的融合正在開啟變革性的可能性，包括術中導航、即時組織識別和針對特定手術的決策支援。人工智慧的整合使機器人系統能夠從數千個手術影片中學習，識別解剖風險並提案最佳的器械軌跡。半自動功能（即機器人輔助完成特定子任務，而外科醫生保持完全控制）正在透過臨床檢驗流程不斷發展。這些創新有望縮短手術時間、減少併發症並提升經驗不足的外科醫生的能力，從而顯著擴大目標市場，並最終推動機器人手術在更廣泛的醫院和外科專科領域的實用化。

關於自主手術職能的法規與責任不確定性

隨著機器人手術平台日益融入自主功能，監管機構面臨著為人工智慧主導的手術決策建立適當核准框架的挑戰。目前，半自動手術功能缺乏明確的分類指南，這給進入市場的開發人員帶來了不確定性，並延長了核准流程。同時，在大多數司法管轄區，由人工智慧驅動而非外科醫生直接判斷導致的不利事件的法律責任問題仍未解決。這種監管上的模糊性削弱了投資者的信心，延緩了下一代平台的商業化進程，造成了結構性阻力，整個產業必須透過實證建議和相關人員的合作來共同應對。

新冠疫情的感染疾病：

新冠疫情促使醫院優先考慮感染疾病控制，導致擇期手術暫時減少，機器人手術數量和系統部署數也出現短期下降。然而，這場危機凸顯了機器人平台在提供微接觸手術環境方面的價值，並證明了它們即使在疫情期間也能安全地維持某些重要手術。隨著疫情後擇期手術的恢復，積壓的手術需求推動了機器人平台部署的加速。這場危機也凸顯了手術效率和感染控制的重要性，並強化了投資機器人手術的長期臨床和營運意義。

在預測期內，機器人系統細分市場預計將佔據最大的市場佔有率。

在預測期內，機器人系統領域預計將佔據最大的市場佔有率。這反映了醫療機構在外科手術機器人平台這一基礎基礎設施投入的大量資金。整合手術主機、病人推車、視覺系統和機械臂的綜合系統是一項核心技術採購，為後續所有手術活動提供支援。隨著醫院將機器人手術專案擴展到多個專科，對完整系統部署的需求也不斷成長。加之整合機器人系統的高昂價格和多年服務契約，預計該領域將在整個預測期內成為所有地區的主要收入來源。

在預測期內，人工智慧（AI）輔助機器人領域預計將呈現最高的複合年成長率。

在預測期內，人工智慧（AI）輔助機器人領域預計將呈現最高的成長率。 AI整合能夠實現術中導航、組織分類和即時手術回饋，從而顯著提高手術的精確度和安全性。平台開發商加大對基於大規模手術影片資料集訓練的機器學習演算法的投資，正在加速AI輔助功能的成熟。大量臨床證據的快速積累，支持AI驅動的機器人手術能夠改善治療效果，這為醫院升級現有系統以及新用戶將AI整合平台作為標準治療方法提供了強力的動力。

市佔率最大的地區：

在整個預測期內，北美預計將保持最大的市場佔有率。這得益於其高昂的醫療費用支出、機器人手術廣泛的保險報銷以及推動外科創新的緊密大學醫院網路。美國擁有全球最豐富的機器人手術系統部署經驗，並在泌尿系統、婦科和普通外科的年度手術量方面處於領先地位。完善的FDA核准流程和強大的臨床支援體系將繼續推動新系統的應用，並在整個預測期內保持該地區的領先地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率。這反映了中國、印度、韓國和東南亞醫院基礎設施的快速擴張。政府主導的醫療現代化計畫和醫療旅遊的蓬勃發展正推動醫院加強對先進外科技術的投資。人口老化和慢性病負擔加重導致手術數量不斷增加，從而對高效精準的外科解決方案產生了顯著需求。本地製造商也正帶著針對區域市場最佳化的、具有成本競爭力的平台進軍機器人手術市場，進一步擴大了機器人手術在全部區域的普及率和應用範圍。

主要公司：

機器人手術市場的主要參與者包括：Intuitive Surgical、Medtronic plc、Stryker Corporation、Zimmer Biomet、Johnson & Johnson、Smith+Nephew、CMR Surgical、Asensus Surgical、Globus Medical、Accuray Incorporated、THINK Surgical、Moon Surgical、ReniBot Corporation plc、Ompus Corporation。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球機器人手術市場：依組件分類

  • 機器人系統
    • 手術主機
    • 病人推車
    • 視覺系統
    • 機械臂及手術器械
  • 配件和設備
    • 手術器械
    • 末端執行器
    • 鉗子
    • 剪刀
    • 持針器
    • 套管針
    • 網路攝影系統
  • 服務
    • 安裝與整合
    • 維護/修理
    • 培訓和教育
    • 軟體升級和支援

第6章：全球機器人手術市場：依手術類型分類

  • 一般外科
  • 婦科手術
  • 泌尿系統手術
  • 整形外科手術
  • 神經外科
  • 心血管外科
  • 胸腔外科
  • 大腸直腸手術
  • 減重手術

第7章：全球機器人手術市場：依機器人類型分類

  • 手術機器人系統
  • 復健機器人系統
  • 用於放射外科手術的機器人
  • 藥局自動化機器人
  • 機器人導管系統

第8章：全球機器人手術市場：依技術分類

  • 人工智慧輔助機器人手術
  • 影像導引機器人手術
  • 基於機器學習的外科手術系統
  • 觸覺技術
  • 雲端連接手術平台
  • 3D可視化和導航系統

第9章：全球機器人手術市場：依應用分類

  • 微創手術
  • 腹腔鏡手術
  • 內視鏡手術
  • 顯微外科手術
  • 復健及輔助手術
  • 遠距手術

第10章：全球機器人手術市場：以最終用戶分類

  • 醫院
  • 門診手術中心（ASC）
  • 專科診所
  • 學術研究機構

第11章：全球機器人手術市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Intuitive Surgical
  • Medtronic plc
  • Stryker Corporation
  • Zimmer Biomet
  • Johnson & Johnson
  • Smith+Nephew
  • CMR Surgical
  • Asensus Surgical
  • Globus Medical
  • Accuray Incorporated
  • THINK Surgical
  • Moon Surgical
  • Renishaw plc
  • Olympus Corporation
  • MicroPort MedBot
Product Code: SMRC36601

According to Stratistics MRC, the Global Robotic Surgery Market is accounted for $8.4 billion in 2026 and is expected to reach $26.7 billion by 2034, growing at a CAGR of 15.5% during the forecast period. Robotic Surgery refers to minimally invasive surgical procedures performed with the assistance of computer-controlled robotic systems that translate a surgeon's hand movements into precise instrument actions within the patient's body. These systems comprise a surgeon console, patient cart with robotic arms, and advanced imaging components that deliver magnified, high-definition visualization. By enhancing surgical dexterity, reducing tremor, and enabling access to confined anatomical spaces, robotic surgery improves procedural accuracy, diminishes postoperative complications, and accelerates patient recovery across a wide spectrum of surgical specialties.

Market Dynamics:

Driver:

Growing preference for minimally invasive surgical procedures and improved patient outcomes

Patients and clinical institutions increasingly favor minimally invasive surgery for its association with reduced blood loss, shorter hospital stays, lower infection risk, and faster return to normal activity. Robotic systems deliver a level of precision and control that surpasses traditional laparoscopic instruments, enabling surgeons to perform complex procedures with greater confidence. The expanding evidence base demonstrating superior clinical outcomes in urological, gynecological, and general surgery applications is accelerating adoption across both academic medical centers and community hospitals. As awareness grows among both surgeons and patients, the procedural volume supported by robotic platforms continues to rise.

Restraint:

Prohibitive capital cost and high maintenance expenditure of robotic surgical systems

The acquisition of a robotic surgical system requires a multimillion-dollar upfront investment, creating a substantial financial barrier particularly for community hospitals and healthcare providers in emerging markets. Beyond initial procurement, ongoing costs including instrument replacement, software licensing, service contracts, and surgical training programs impose a heavy recurrent financial burden. Reimbursement frameworks in many healthcare systems have not kept pace with the actual cost of robotic procedures, compressing hospital margins. These economic constraints limit the diffusion of robotic surgery beyond large tertiary centers, slowing the overall pace of market penetration despite strong clinical advocacy.

Opportunity:

Emergence of AI-integrated and autonomous surgical robotic platforms

The convergence of artificial intelligence with robotic surgery is opening transformative possibilities including intraoperative guidance, real-time tissue recognition, and procedure-specific decision support. AI integration enables robotic systems to learn from thousands of surgical videos, flagging anatomical risks and suggesting optimal instrument trajectories. Semi-autonomous capabilities where the robot assists with defined subtasks while the surgeon retains full control are advancing through clinical validation pipelines. These innovations are expected to reduce procedure times, lower complications, and extend the capabilities of less-experienced surgeons, significantly broadening the addressable market and making robotic surgery viable across a wider range of hospitals and surgical specialties.

Threat:

Regulatory and liability uncertainties surrounding autonomous surgical functionalities

As robotic surgery platforms incorporate increasingly autonomous features, regulatory agencies face the challenge of establishing appropriate approval frameworks for AI-driven surgical decision-making. The absence of clear classification guidelines for semi-autonomous surgical functions creates market entry uncertainty for developers and prolonged approval timelines. Simultaneously, questions of legal liability in cases of adverse outcomes attributable to AI-driven actions rather than direct surgeon decisions remain unresolved in most jurisdictions. These regulatory ambiguities dampen investor confidence and slow commercialization of next-generation platforms, representing a structural headwind that the industry must collectively address through evidence-based advocacy and stakeholder engagement.

Covid-19 Impact:

The COVID-19 pandemic temporarily suppressed elective surgical volumes as hospitals prioritized infectious disease management, causing a short-term contraction in robotic surgery procedure counts and system installations. However, the crisis underscored the value of robotic platforms in enabling reduced-contact surgical environments and demonstrated their role in maintaining certain essential surgeries safely during the pandemic period. As elective procedure volumes rebounded post-pandemic, pent-up surgical demand fueled accelerated platform adoption. The crisis also highlighted the importance of surgical efficiency and infection control, reinforcing the long-term clinical and operational rationale for robotic surgery investment.

The robotic systems segment is expected to be the largest during the forecast period

The robotic systems segment is expected to account for the largest market share during the forecast period, reflecting the substantial capital investment that healthcare institutions commit to surgical robotic platforms as foundational infrastructure. Comprehensive systems integrating surgeon consoles, patient carts, vision systems, and robotic arms represent the core technology purchase that enables all downstream procedural activity. As hospitals expand their robotic surgery programs across multiple specialties, demand for complete system installations intensifies. The premium pricing of integrated robotic systems, combined with multi-year service agreements, positions this segment as the primary revenue contributor throughout the forecast period across all geographies.

The artificial intelligence-assisted robotics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the artificial intelligence-assisted robotics segment is predicted to witness the highest growth rate. AI integration enables intraoperative guidance, tissue classification, and real-time procedural feedback that significantly enhances surgical precision and safety. Growing investment by platform developers in machine learning algorithms trained on large surgical video datasets is accelerating the maturation of AI-assisted capabilities. Clinical evidence supporting improved outcomes through AI-augmented robotic procedures is building rapidly, creating compelling incentives for hospitals to upgrade existing systems and for new purchasers to select AI-integrated platforms as their standard of care.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by high healthcare expenditure, widespread insurance reimbursement coverage for robotic procedures, and a dense network of academic medical centers that champion surgical innovation. The United States hosts the largest installed base of surgical robotic systems globally and leads in the number of robotic procedures performed annually across urology, gynecology, and general surgery. Robust FDA approval pathways and strong clinical advocacy communities continue to drive new system introductions, sustaining the region's leadership throughout the forecast horizon.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, reflecting rapid hospital infrastructure expansion in China, India, South Korea, and Southeast Asia. Government health modernization programs and growing medical tourism are stimulating hospital investment in advanced surgical technologies. Rising surgical volumes driven by aging populations and increasing chronic disease burden create significant demand for efficient, precise surgical solutions. Local manufacturers are also entering the robotic surgery space with cost-competitive platforms tailored for regional markets, further broadening accessibility and adoption across the Asia Pacific region.

Key Players:

Some of the key players in the Robotic Surgery Market include Intuitive Surgical, Medtronic plc, Stryker Corporation, Zimmer Biomet, Johnson & Johnson, Smith+Nephew, CMR Surgical, Asensus Surgical, Globus Medical, Accuray Incorporated, THINK Surgical, Moon Surgical, Renishaw plc, Olympus Corporation, and MicroPort MedBot.

Key Developments:

In March 2026, Medtronic plc announced a strategic collaboration with a leading medical imaging firm to integrate real-time intraoperative imaging capabilities into its Hugo robotic-assisted surgery platform, aimed at improving anatomical visualization and expanding the system's clinical application across urological and gynecological surgical specialties.

In January 2026, Intuitive Surgical received FDA clearance for its next-generation da Vinci 5 robotic surgical system featuring enhanced force feedback capabilities and integrated AI-powered intraoperative guidance, enabling surgeons to perform complex minimally invasive procedures with greater precision and improved tactile sensory information during tissue manipulation.

Components Covered:

  • Robotic Systems
  • Accessories & Instruments
  • Services

Surgery Types Covered:

  • General Surgery
  • Gynecological Surgery
  • Urological Surgery
  • Orthopedic Surgery
  • Neurosurgery
  • Cardiovascular Surgery
  • Thoracic Surgery
  • Colorectal Surgery
  • Bariatric Surgery

Robot Types Covered:

  • Surgical Robotic Systems
  • Rehabilitation Robotic Systems
  • Radiosurgery Robots
  • Pharmacy Automation Robots
  • Robotic Catheter Systems

Technologies Covered:

  • Artificial Intelligence-Assisted Robotics
  • Image-Guided Robotic Surgery
  • Machine Learning-Based Surgical Systems
  • Haptic Technology
  • Cloud-Connected Surgical Platforms
  • 3D Visualization & Navigation Systems

Applications Covered:

  • Minimally Invasive Surgery
  • Laparoscopic Surgery
  • Endoscopic Surgery
  • Microsurgery
  • Rehabilitation & Assistive Surgery
  • Teleoperated Surgery

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics
  • Academic & Research Institutes

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 3032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Robotic Surgery Market, By Component

  • 5.1 Robotic Systems
    • 5.1.1 Surgeon Console
    • 5.1.2 Patient Cart
    • 5.1.3 Vision Systems
    • 5.1.4 Robotic Arms & Instruments
  • 5.2 Accessories & Instruments
    • 5.2.1 Surgical Instruments
    • 5.2.2 End Effectors
    • 5.2.3 Forceps
    • 5.2.4 Scissors
    • 5.2.5 Needle Drivers
    • 5.2.6 Trocars
    • 5.2.7 Camera Systems
  • 5.3 Services
    • 5.3.1 Installation & Integration
    • 5.3.2 Maintenance & Repair
    • 5.3.3 Training & Education
    • 5.3.4 Software Upgrades & Support

6 Global Robotic Surgery Market, By Surgery Type

  • 6.1 General Surgery
  • 6.2 Gynecological Surgery
  • 6.3 Urological Surgery
  • 6.4 Orthopedic Surgery
  • 6.5 Neurosurgery
  • 6.6 Cardiovascular Surgery
  • 6.7 Thoracic Surgery
  • 6.8 Colorectal Surgery
  • 6.9 Bariatric Surgery

7 Global Robotic Surgery Market, By Robot Type

  • 7.1 Surgical Robotic Systems
  • 7.2 Rehabilitation Robotic Systems
  • 7.3 Radiosurgery Robots
  • 7.4 Pharmacy Automation Robots
  • 7.5 Robotic Catheter Systems

8 Global Robotic Surgery Market, By Technology

  • 8.1 Artificial Intelligence-Assisted Robotics
  • 8.2 Image-Guided Robotic Surgery
  • 8.3 Machine Learning-Based Surgical Systems
  • 8.4 Haptic Technology
  • 8.5 Cloud-Connected Surgical Platforms
  • 8.6 3D Visualization & Navigation Systems

9 Global Robotic Surgery Market, By Application

  • 9.1 Minimally Invasive Surgery
  • 9.2 Laparoscopic Surgery
  • 9.3 Endoscopic Surgery
  • 9.4 Microsurgery
  • 9.5 Rehabilitation & Assistive Surgery
  • 9.6 Teleoperated Surgery

10 Global Robotic Surgery Market, By End User

  • 10.1 Hospitals
  • 10.2 Ambulatory Surgical Centers (ASCs)
  • 10.3 Specialty Clinics
  • 10.4 Academic & Research Institutes

11 Global Robotic Surgery Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Intuitive Surgical
  • 14.2 Medtronic plc
  • 14.3 Stryker Corporation
  • 14.4 Zimmer Biomet
  • 14.5 Johnson & Johnson
  • 14.6 Smith+Nephew
  • 14.7 CMR Surgical
  • 14.8 Asensus Surgical
  • 14.9 Globus Medical
  • 14.10 Accuray Incorporated
  • 14.11 THINK Surgical
  • 14.12 Moon Surgical
  • 14.13 Renishaw plc
  • 14.14 Olympus Corporation
  • 14.15 MicroPort MedBot

List of Tables

  • Table 1 Global Robotic Surgery Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Robotic Surgery Market Outlook, By Component (2023-2034) ($MN)
  • Table 3 Global Robotic Surgery Market Outlook, By Robotic Systems (2023-2034) ($MN)
  • Table 4 Global Robotic Surgery Market Outlook, By Surgeon Console (2023-2034) ($MN)
  • Table 5 Global Robotic Surgery Market Outlook, By Patient Cart (2023-2034) ($MN)
  • Table 6 Global Robotic Surgery Market Outlook, By Vision Systems (2023-2034) ($MN)
  • Table 7 Global Robotic Surgery Market Outlook, By Robotic Arms & Instruments (2023-2034) ($MN)
  • Table 8 Global Robotic Surgery Market Outlook, By Accessories & Instruments (2023-2034) ($MN)
  • Table 9 Global Robotic Surgery Market Outlook, By Surgical Instruments (2023-2034) ($MN)
  • Table 10 Global Robotic Surgery Market Outlook, By End Effectors (2023-2034) ($MN)
  • Table 11 Global Robotic Surgery Market Outlook, By Forceps (2023-2034) ($MN)
  • Table 12 Global Robotic Surgery Market Outlook, By Scissors (2023-2034) ($MN)
  • Table 13 Global Robotic Surgery Market Outlook, By Needle Drivers (2023-2034) ($MN)
  • Table 14 Global Robotic Surgery Market Outlook, By Trocars (2023-2034) ($MN)
  • Table 15 Global Robotic Surgery Market Outlook, By Camera Systems (2023-2034) ($MN)
  • Table 16 Global Robotic Surgery Market Outlook, By Services (2023-2034) ($MN)
  • Table 17 Global Robotic Surgery Market Outlook, By Installation & Integration (2023-2034) ($MN)
  • Table 18 Global Robotic Surgery Market Outlook, By Maintenance & Repair (2023-2034) ($MN)
  • Table 19 Global Robotic Surgery Market Outlook, By Training & Education (2023-2034) ($MN)
  • Table 20 Global Robotic Surgery Market Outlook, By Software Upgrades & Support (2023-2034) ($MN)
  • Table 21 Global Robotic Surgery Market Outlook, By Surgery Type (2023-2034) ($MN)
  • Table 22 Global Robotic Surgery Market Outlook, By General Surgery (2023-2034) ($MN)
  • Table 23 Global Robotic Surgery Market Outlook, By Gynecological Surgery (2023-2034) ($MN)
  • Table 24 Global Robotic Surgery Market Outlook, By Urological Surgery (2023-2034) ($MN)
  • Table 25 Global Robotic Surgery Market Outlook, By Orthopedic Surgery (2023-2034) ($MN)
  • Table 26 Global Robotic Surgery Market Outlook, By Neurosurgery (2023-2034) ($MN)
  • Table 27 Global Robotic Surgery Market Outlook, By Cardiovascular Surgery (2023-2034) ($MN)
  • Table 28 Global Robotic Surgery Market Outlook, By Thoracic Surgery (2023-2034) ($MN)
  • Table 29 Global Robotic Surgery Market Outlook, By Colorectal Surgery (2023-2034) ($MN)
  • Table 30 Global Robotic Surgery Market Outlook, By Bariatric Surgery (2023-2034) ($MN)
  • Table 31 Global Robotic Surgery Market Outlook, By Robot Type (2023-2034) ($MN)
  • Table 32 Global Robotic Surgery Market Outlook, By Surgical Robotic Systems (2023-2034) ($MN)
  • Table 33 Global Robotic Surgery Market Outlook, By Rehabilitation Robotic Systems (2023-2034) ($MN)
  • Table 34 Global Robotic Surgery Market Outlook, By Radiosurgery Robots (2023-2034) ($MN)
  • Table 35 Global Robotic Surgery Market Outlook, By Pharmacy Automation Robots (2023-2034) ($MN)
  • Table 36 Global Robotic Surgery Market Outlook, By Robotic Catheter Systems (2023-2034) ($MN)
  • Table 37 Global Robotic Surgery Market Outlook, By Technology (2023-2034) ($MN)
  • Table 38 Global Robotic Surgery Market Outlook, By Artificial Intelligence-Assisted Robotics (2023-2034) ($MN)
  • Table 39 Global Robotic Surgery Market Outlook, By Image-Guided Robotic Surgery (2023-2034) ($MN)
  • Table 40 Global Robotic Surgery Market Outlook, By Machine Learning-Based Surgical Systems (2023-2034) ($MN)
  • Table 41 Global Robotic Surgery Market Outlook, By Haptic Technology (2023-2034) ($MN)
  • Table 42 Global Robotic Surgery Market Outlook, By Cloud-Connected Surgical Platforms (2023-2034) ($MN)
  • Table 43 Global Robotic Surgery Market Outlook, By 3D Visualization & Navigation Systems (2023-2034) ($MN)
  • Table 44 Global Robotic Surgery Market Outlook, By Application (2023-2034) ($MN)
  • Table 45 Global Robotic Surgery Market Outlook, By Minimally Invasive Surgery (2023-2034) ($MN)
  • Table 46 Global Robotic Surgery Market Outlook, By Laparoscopic Surgery (2023-2034) ($MN)
  • Table 47 Global Robotic Surgery Market Outlook, By Endoscopic Surgery (2023-2034) ($MN)
  • Table 48 Global Robotic Surgery Market Outlook, By Microsurgery (2023-2034) ($MN)
  • Table 49 Global Robotic Surgery Market Outlook, By Rehabilitation & Assistive Surgery (2023-2034) ($MN)
  • Table 50 Global Robotic Surgery Market Outlook, By Teleoperated Surgery (2023-2034) ($MN)
  • Table 51 Global Robotic Surgery Market Outlook, By End User (2023-2034) ($MN)
  • Table 52 Global Robotic Surgery Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 53 Global Robotic Surgery Market Outlook, By Ambulatory Surgical Centers (ASCs) (2023-2034) ($MN)
  • Table 54 Global Robotic Surgery Market Outlook, By Specialty Clinics (2023-2034) ($MN)
  • Table 55 Global Robotic Surgery Market Outlook, By Academic & Research Institutes (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.